Back to search
FDAFDA · Food and drugs·Recall number D-0038-2025

Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.

Published November 13, 2024 · Recall initiated: October 29, 2024

Summary

FDA records drug Class II recall D-0038-2025, published November 13, 2024 and initiated October 29, 2024. Recalling firm: VIONA PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 6048 pumps; Lot: Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization

What to do

Voluntary: Firm initiated · Letter

Get an email if DAPSONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAPSONE
Manufacturer
VIONA PHARMACEUTICALS INC
Distributor
USA Nationwide
Lot
Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. recalled?

Yes. FDA published recall D-0038-2025 on November 13, 2024. Reported hazard: Crystallization

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAPSONE.